---
$id: https://graph.org.ai/products/commodity/51142552
$type: Product
source: UNSPSC
code: "51142552"
title: "Lazabemide hydrochloride"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lazabemide hydrochloride

**UNSPSC Code**: 51142552
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a monoamine oxidase inhibitor C8H10ClN3O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PI150J9ZX1, chemically known as 2-pyridinecarboxamide, n-(2-aminoethyl)-5-chloro-, monohydrochloride, but more generally known as lazabemide hydrochloride, which bears US NIH Compound Identifier 163727. Most nations, for tariff and trade purposes, schedule lazabemide hydrochloride under HS 29333999 and SITC 51574. As of Q4 2014, LAZABEMIDE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Lazabemide hydrochloride bears US NLM identifiers UMLS ID C2825397 and NCI Concept Code C80968. SMILES: C1CC(NCC1CL)C(=O)NCCN.CL.

